Integrated DNA Technologies Inc. Products & Reviews

Design primers to your sequence of interest

Multiplexing 2 to 5 qPCR targets in a single reaction can generate more data per sample.

RT-qPCR Master Mix that is specifically formulated for one-step RT-qPCR reactions.

Premium RT-qPCR Master Mix that is specifically formulated for one-step RT-qPCR reactions.

Primer-only premixed assays for analyzing gene expression using intercalating dyes

Obtain high purity DNA and RNA oligos in bulk quantities.

Using IDT as a third-party OEM supplier gives you access to our entire catalog of genomics products, as well as a full-range of custom services

Use MGB Eclipse Probes to create shortened probes with high sequence discrimination.

Available oligo modifications

PrimeTime qPCR Probes are 5' nuclease probes that include a fluorescent reporter dye and one or two quencher dye(s).

Detect single mismatch from target with hybridization probes

Primers and probes for MonkeyPox research

LiquidPlex panel is an advanced and user-friendly research assay for targeted next generation sequencing of circulating cell-free tumor DNA (ccfDNA/cfDNA/ctDNA) from 28 genes commonly associated with solid tumor type cancers.

FusionPlex Lung v2 is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 17 genes associated with NSCLC.

FusionPlex Core Solid Tumor is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 57 genes associated with various solid tumor malignancies.

FusionPlex Core Solid Tumor is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 57 genes associated with various solid tumor malignancies.

FusionPlex Pan Solid V2 is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 137 genes associated with various solid tumor malignancies.

Immunoverse is a research assay that characterizes the immune repertoire, including assessment of T- and B-cell clonalities and rare clones, and detection of tumor infiltrating lymphocytes (TIL) and somatic hypermutation with targeted NGS of key T cell receptor and B cell receptor chain RNA relevant for blood cancer and solid tumor research.

FusionPlex Pan Heme is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, expression, and fusions, including novel fusions, from 199 genes associated with lymphoid and myeloid malignancies.

FusionPlex Heme V2 is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, expression, and fusions, including novel fusions, from 87 genes associated with lymphoid and myeloid malignancies.

FusionPlex Myeloid is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, expression, and fusions, including novel fusions, from 84 genes associated with myeloid-origin malignancies.

FusionPlex Lymphoma is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, expression, and fusions, including novel fusions, from 125 genes associated with lymphomas.

FusionPlex ALL is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, expression, and fusions, including novel fusions, from 81 genes associated with acute lymphoblastic leukemia (ALL) .

Ideal for small scale in vitro applications, screening DsiRNA duplex pricing includes affinity purification.

Custom DNA oligos—manufactured and shipped the same day you order